“…The turkey samples were the source of 30 C. jejuni strains and 1 C. coli strain, while the number of C. jejuni and C. coli isolates from the broiler faeces was 11 and 3, respectively minimum inhibitory concentration (MIC); molecular methods | Strains susceptible to azithromycin, erythromycin, gentamicin, florfenicol, telithromycin, clindamycin; all strains resistant to ciprofloxacin; 92.9% strains from broiler resistant to nalidixic acid and 78.6% strains resistant to tetracycline; 83.9% strains from turkey resistant to nalidixic acid and 58.1% % strains resistant to tetracycline | all strains resistant to ciprofloxacin had a mutation in the gyr A gene at Thr-86 position; presence of the tet O gene in 71% of isolates from the turkey and in100% of isolates from the broiler; all strains resistant to tetracyclines contained the tet O gene; 5 strains from turkey faeces and 3 strains from broiler faeces susceptible to tetracycline contained the tet O gene | Woźniak-Biel et al 2018 (PL) | 3 poultry farms | various waste materials collected on poultry farms: 4 feather samples (duck, turkey, chicken), sludge (2 samples) centrifuge sediment (2 samoles) | selective medium | 100 strains of Enterococcus genus identified as Enterococcus faecalis (21%) , Enterococcus faecium (79%) | Chromogenic differentiating medium ChromID VRE; disc diffusion method | More than 50% of the strains demonstrated resistance to 19 out of 23 antibiotics. The highest resistance in the case of streptogramins, carbapenems, fluoroquinolones, aminoglycosides, penicillins; the lowest in the case of nitrofurantoin and chloramphenicol; E. faecalis strains were more resistant than the E. faecium; presence of multidrug resistance of isolates | - | Cybulska and Krzyśko-Łupicka 2020 (PL) |
| environmental samples from chicken broilers, turkey broilers and laying hens; 51 isolates from 2 veterinary laboratories originated from livestock environment; | n/a | Salmonella enterica ser. Enteritidis | minimum inhibitory concentration (MIC); molecular methods | all isolates susceptible to gentamicin, tazobactam, cefotaxime, meropenem, azithromycin, tigecycline and trimethoprim, ampicillin, 84.3% isolates resistant to colistin, 56.9% to sulfamethoxazole; 41.2% to nalidixic acid, 21.6% to tetracycline, 3.9% to chloramphenicol, 2.0% to ciprofloxacin | 14 isolates showing multidrug resistance; resistance genes: flo R (51.0%), bla TEM (35.3%), bla PSE (5... |
…”